Recent advances in immuno-oncol- ogy and its application to urological cancers. BJU Int 2016; 118: 506-514.Mataraza JM, Gotwals P. Recent advances in immuno-oncology and its application to urological cancers. BJU Int. 2016;118: 506-14....
they are more labor-intensive and have lower throughput than pooled arrays; thereby, studies extensively apply pooled screens for discovery. CRISPR has unraveled several molecules in the immune-oncology field. Therefore, we list the recent findings...
they are more labor-intensive and have lower throughput than pooled arrays; thereby, studies extensively apply pooled screens for discovery. CRISPR has unraveled several molecules in the immune-oncology field. Therefore, we list the recent findings...
Currently Director of the Pathophysiology of Anemia Unit and Associate Professor in Blood Diseases, Oncology and Rheumatology. She is involved in the diagnosis and clinical care of patients with immuno-mediated cytopenias, and congenital and acquired rare anemias....
Immuno-Biological Markers Collaboration to prioritize sTILs in experimental research and clinical applications [240]. The combinatory predictive value of TILs and PD-L1 has been validated in multiple clinical trials, leading to their inclusion in the NCCN guidelines for breast cancer, offering insights ...
This Review discusses the major advances and changes made over the past 3 years to our understanding of chimeric antigen receptor (CAR) T cell efficacy and safety. Recently, the field has gained insight into how various molecular modules of the CAR in
I would say that the more immediate things occurring in the field that will garner a lot of press are the use of immunooncology agents such as PD-1/PD-L1 antibodies and selecting patient populations for that. Also, the introduction of PARP inhibitors for homologous recombination deficient pati...
immuno-oncology, bringing world-renowned experts to present groundbreaking innovations in basic, translational, and clinical cancer research. Six sessions focused on cellular therapies, digital pathology, vaccines, tertiary lymphoid structures, and microenvironment in order to get deep insights on how to ...
Immuno-Oncology Stars Keytruda, Opdivo Likely To Come Into IRA Crosshairs May 28, 2025 · 2 min read · Annalee Armstrong Layoffs AbbVie’s Allergan Cuts Over 200 Staff After Botched Marketing Campaign May 28, 2025 · 2 min read ·
into cell lines that are cultured either as monolayers or in suspension in immunodeficient mice [52]. Recent studies have incorporated PDCs or patient-derived spheroids (PDSs) with 3DP technology to create valuable ex vivo and in vitro models. These models provide an essential tool for various ...